2,5-DMA

2,5-Dimethoxyamphetamine (2,5-DMA) is a substituted amphetamine and early member of the phenethylamine family first synthesized and characterized by Alexander Shulgin. Unlike the better-known 2C-x series, 2,5-DMA lacks a 4-position substituent and consequently produces primarily stimulant effects with minimal psychedelic character at typical doses — making it pharmacologically distinct from the richly hallucinogenic 2C compounds that would follow in Shulgin's research program.

The compound was documented in Shulgin's landmark 1991 book PiHKAL: A Chemical Love Story, where it is described as producing mild stimulation, mood elevation, and sensory heightening at doses in the 80–160 mg range, with a duration of 8–12 hours. Shulgin himself found it underwhelming as a psychedelic but noted its stimulant character with interest. Its research value lay partly in establishing what substitution pattern was necessary to produce psychedelic effects — a question that drove the development of the entire 2C series.

As a relatively obscure compound with little human use data and no clinical research, 2,5-DMA occupies an interesting historical niche as a chemical stepping stone rather than a destination. It represents the point in Shulgin's systematic exploration of phenethylamine structure-activity relationships where the 4-position substituent was identified as essential to psychedelic activity. The compound carries all the legal restrictions of its more notorious relatives and should be approached with corresponding caution given the sparse safety data.